$ARGS Headlines On first trading day, Argos fl

$ARGS Headlines

On first trading day, Argos flies high — only to end back where it started 5:47 p.m. Feb. 7, 2014 - Russ Britt

10-Q: ARGOS THERAPEUTICS INC 2:45 p.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Argos Therapeutics' (ARGS) CEO Jeff Abbey on Q2 2014 Results - Earnings Call Transcript 8:46 p.m. Aug. 13, 2014 - Seeking Alpha
Weekly 3-Year Low Highlights: VCRA, CLUB, ARGS, ONTX, BOTA 5:27 p.m. June 8, 2014 - GuruFocus.com
10-Q: ARGOS THERAPEUTICS INC 2:52 p.m. May 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: ARGOS THERAPEUTICS INC 4:09 p.m. March 31, 2014 - Edgar Online - (EDG = 10Q, 10K)
Argos Therapeutics: Cancer Immunotherapy Using A Noble Prize Winning Discovery 6:54 p.m. Feb. 19, 2014 - Seeking Alpha
Argos Therapeutics: No Light At The End Of The Tunnel 3:22 p.m. Feb. 11, 2014 - Seeking Alpha
IPO Preview: Argos Therapeutics 1:18 a.m. Feb. 7, 2014 - Seeking Alpha

Argos Therapeutics to Hold Second Quarter 2014 Financial Results Conference Call on Wednesday, August 13, 2014 8:31 a.m. Aug. 6, 2014 - GlobeNewswire
Argos Therapeutics to Present at Two Upcoming Healthcare Conferences 8:01 a.m. June 11, 2014 - GlobeNewswire
Argos Therapeutics to Host Post-American Society of Clinical Oncology (ASCO) Conference Call and Webcast, Monday, June 9, 2014 8:02 a.m. June 5, 2014 - GlobeNewswire
Treatment With AGS-003 and Sunitinib Associated With Doubling of Expected Survival in Patients With Unfavorable Risk Metastatic Renal Cell Carcinoma (mRCC) 9:36 a.m. June 2, 2014 - GlobeNewswire
Argos Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference 8:02 a.m. May 28, 2014 - GlobeNewswire
Argos Therapeutics Named as a Red Herring Top 100 North America Winner 9:06 a.m. May 27, 2014 - GlobeNewswire
Argos Therapeutics CSO Dr. Charles Nicolette to Join Panel Discussion on Challenges in Clinical Trial Development at the Society of Gene & Cell Therapy Annual Meeting 4:31 p.m. May 19, 2014 - GlobeNewswire
Argos Therapeutics COO Fred Miesowicz to Join Panel Discussion on Manufacturing Challenges in Cell Therapy at the World Stem Cells and Regenerative Medicine Congress 4:32 p.m. May 15, 2014 - GlobeNewswire
Argos Therapeutics to Present Data Related to Clinical Development Program for AGS-003 During 2014 ASCO Annual Meeting 4:07 p.m. May 12, 2014 - GlobeNewswire
Argos Therapeutics to Hold First Quarter 2014 Financial Results Conference Call on Tuesday, May 13, 2014 8:02 a.m. April 29, 2014 - GlobeNewswire
Argos Therapeutics Announces Filing of Its Annual Report on Form 10-K 4:46 p.m. April 7, 2014 - GlobeNewswire
Argos Therapeutics to Present at the 13th Annual Needham Healthcare Conference 4:31 p.m. April 1, 2014 - GlobeNewswire
Argos Therapeutics Added to Russell 2000(R) and 3000(R) Indexes 4:37 p.m. March 31, 2014 - GlobeNewswire
Argos Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results 4:12 p.m. March 27, 2014 - GlobeNewswire
Argos Therapeutics to Present at 21st Annual Future Leaders in the Biotech Industry Conference 12:30 p.m. March 21, 2014 - GlobeNewswire
Argos Therapeutics to Present at Regenerative Medicine and Cancer Immunotherapy Meetings 4:45 p.m. March 19, 2014 - GlobeNewswire
Argos Therapeutics to Present at the 2nd Annual Sachs Cancer Bio Partnering & Investment Forum 9:03 a.m. March 17, 2014 - GlobeNewswire
Argos Therapeutics to Hold Fourth Quarter and Year End 2013 Financial Results Conference Call on Thursday, March 27, 2014 4:05 p.m. March 14, 2014 - GlobeNewswire
Argos Therapeutics Presents New Data From Clinical Research for AGS-004 Patient-Specific Immunotherapy in Treatment of HIV 5:00 p.m. March 4, 2014 - GlobeNewswire
Forbion Announces Closing of Public Offering of Portfolio Company, Argos Therapeutics 10:24 a.m. Feb. 20, 2014 - BusinessWire - BZX